Update on 3-iodothyronamine and its neurological and metabolic actions

Frontiers in Physiology

Volumn 5, Issue OCT, 2014, Pages

  Zucchi, Riccardo ^a   Accorroni, Alice ^a   Chiellini, Grazia ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

3 iodothyronamine; Diabetes mellitus; Learning; Lipid metabolism; Memory; Neuromodulation; T1am; Thyroid hormones

Indexed keywords

3 IODOTHYRONAMINE; ALPHA 2A ADRENERGIC RECEPTOR; APOLIPOPROTEIN B100; BIOGENIC AMINE; DOPAMINE TRANSPORTER; G PROTEIN COUPLED RECEPTOR; GLUCAGON; GLUCOSE; IMIDAZOLE DERIVATIVE; LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; NORADRENALIN TRANSPORTER; OLANZAPINE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RO 5256390; RO 5263397; THYROXINE; TRACE AMINE ASSOCIATED RECEPTOR 1; TRACE AMINE ASSOCIATED RECEPTOR 1 AGONIST; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2;

BINDING SITE; EXPLORATORY BEHAVIOR; FATTY ACID METABOLISM; FOOD INTAKE; GLUCAGON RELEASE; GLUCONEOGENESIS; GLYCOLYSIS; HUMAN; HYPERACTIVITY; HYPERGLYCEMIA; INSULIN RELEASE; KETOGENESIS; LEARNING; LIPID OXIDATION; LOCUS CERULEUS; MEMORY; METABOLISM; NERVOUS SYSTEM FUNCTION; NEUROMODULATION; NONHUMAN; NONREM SLEEP; PAIN THRESHOLD; REVIEW; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

EID: 84908376392     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00402     Document Type: Review

References (111)

1. Ackermans, M. T., Klieverik, L. P., Ringeling, P., Endert, E., Kalsbeek, A., and Fliers, E., (2010). An online solid-phase extraction-liquid chromatography-tandem mass spectrometry method to study the presence of thyronamines in plasma and tissue and their putative conversion from 13C6-thyroxine. J. Endocrinol. 206, 327-334 doi: 10.1677/JOE-10-0060
2. Agretti, P., De Marco, G., Russo, L., Saba, A., Raffaelli, A., Marchini, M., et al. (2011). 3-Iodothyronamine metabolism and metabolic effects in FRTL5 thyroid cells. J. Mol. Endocrinol. 47, 23-32. doi: 10.1530/JME-10-0168
3. Alkemade, A., Friesema, E. C., Unmehopa, U. A., Fabriek, B. O., Kuiper, G. G., Leonard, J. L., et al. (2005). Neuroanatomical pathways for thyroid hormone feedback in the human hypothalamus. J. Clin. Endocrinol. Metab. 90, 4322-4334. doi: 10.1210/jc.2004-2567
4. Alzoubi, K. H., Gerges, N. Z., Aleisa, A. M., and Alkadhi, K. A. (2009). Levothyroxin restores hypothyroidism-induced impair-ment of hippocampus-dependent learning and memory: behavioral, electrophysiological, and molecular studies. Hippocampus 19, 66-78. doi: 10.1002/hipo.20476
5. Andrews, G. D., and Lavin, A. (2006). Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors. Neuropsychopharmacology 31, 594-601. doi: 10.1038/sj.npp.1300818
6. Bauer, M., Heinz, A., and Whybrow, P. C. (2002). Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry 7, 140-156. doi: 10.1038/sj.mp.4000963
7. Blake, T. J., Tillery, C. E., and Reynolds, G. P. (1998). Antipsychotic drug affinities at alpha2-adrenoceptor subtypes in post-mortem human brain. J. Psychopharmacol. 12, 151-154. doi: 10.1177/026988119801200206
8. Borowsky, B., Adham, N., Jones, K. A., Raddaz, R., Artymyshyn, R., Ogozalek, K. L., et al. (2001). Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 8966-8971. doi: 10.1073/pnas.151105198
9. Bradaia, A., Trube, G., Stalder, H., Norcross, R. D., Ozmen, L., Wettstein, J. G., et al. (2009). The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc. Natl. Acad. Sci. U.S.A. 106, 20081-20086. doi: 10.1073/pnas.0906522106
10. Braulke, L. J., Klingenspor, M., DeBarber, A., Tobias, S. C., Grandy, D. K., Scanlan, T. S., et al. (2008). 3-Iodothyronamine: a novel hormone controlling the balance between glucose and lipid utilisation. J. Comp. Physiol. B 178, 167-177. doi: 10.1007/s00360-007-0208-x
11. Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., et al. (2001). Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol. Pharmacol. 60, 1181-1188. doi: 10.1124/mol.60.6.1181
12. Buzsaki, G., and Draguhn, A. (2004). Neuronal oscillations in cortical networks. Science 304, 1926-1929. doi: 10.1126/science.1099745
13. Caria, M. A., Dratman, M. B., Kow, L. M., Mameli, O., and Pavlides, C. (2009). Thyroid hormone action: nongenomic modulation of neuronal excitability in the hippocampus. J. Neuroendocrinol. 21, 98-107. doi: 10.1111/j.1365-2826.2008.01813.x
14. Chapell, R., Martin, J., Machu, T. K., and Leidenheimer, N. J. (1998). Direct channel-gating and modulatory effects of triiodothyronine on recombinant GABA(A) receptors. Eur. J. Pharmacol. 349, 115-121. doi: 10.1016/S0014-2999(98)00182-4
15. Cheng, L. Y., Outterbridge, L. V., Covatta, N. D., Martens, D. A., Gordon, J. T., and Dratman, M. B. (1994). Film autoradiography identifies unique features of [125I]3,3'5'-(reverse) triiodothyronine transport from blood to brain. J Neurophysiol 72, 380-391.
16. Chiellini, G., Assadi-Porter, F. M., Reiland, H., Carnicelli, V., Butz, D., Tonelli, M., et al. (2013). Weight loss with preserved glucose homeostasis during chronic treatment of obese mice with 3-iodothyronamine (T1AM): role of the sirtuin family [abstract]. Eur. Thyroid J. 2, 85. doi: 10.1159/000352096
17. Chiellini, G., Erba, P., Carnicelli, V., Manfredi, C., Frascarelli, S., Ghelardoni, S., et al. (2012). Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. J. Endocrinol. 213, 223-230. doi: 10.1530/JOE-12-0055
18. Chiellini, G., Frascarelli, S., Ghelardoni, S., Carnicelli, V., Tobias, S. C., DeBarber, A., et al. (2007). Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function. FASEB J. 21, 1597-1608. doi: 10.1096/fj.06-7474com
19. Chiellini, G., Rapposelli, S., Digiacomo, M., Espinoza, S., Sabatini, M., and Frascarelli, S., et al. (2014). Novel synthetic thyronamines as new powerful TAAR1 agonists [abstract]. Eur. Thyroid J. 3, 187. doi: 10.1159/000365244
20. Cohn, C. K., Ball, G. G., and Hirsch, J. (1973). Histamine: effect on self-stimulation. Science 180, 757-758. doi: 10.1126/science.180.4087.757
21. Crutchfield, F. L., and Dratman, M. B. (1983). Early ontogeny of iodocompound-processing neural systems in rat brain. Pediatr. Res. 17, 8-14 doi: 10.1203/00006450-198301000-00002
22. Cumero, S., Fogolari, F., Domenis, R., Zucchi, R., Mavelli, I., and Contessi, S. (2012). Mitochondrial F0-F1-ATP synhase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone. Br. J. Pharmacol. 166, 2331-2347. doi: 10.1111/j.1476-5381.2012.01958.x
23. DeNiro, M. J., and Epstein, S. (1977). Mechanism of carbon isotope fractionation associated with lipid synthesis. Science 197, 261-263. doi: 10.1126/science.327543
24. Dhillo, W. S., Bewick, G. A., White, N. E., Gardiner, J. V., Thompson, E. L., Bataveljic, A., et al. (2009). The thyroid hormone derivative 3-iodothyronamine increases food intake in rodents. Diabetes Obes. Metab. 11, 251-260. doi: 10.1111/j.1463-1326.2008.00935.x
25. Doyle, K. P., Suchland, K. L., Ciesielski, T. M., Lessov, N. S., Grandy, D. K., Scanlan, T. S., et al. (2007). Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38, 2569-2576. doi: 10.1161/STROKEAHA.106.480277
26. Dratman, M. B., and Crutchfield, F. L. (1978). Synaptosomal [125I]triiodothyronine after intravenous [125I]thyroxine. Am. J. Physiol. 235, E638-E647.
27. Dratman, M. B., Crutchfield, F. L., Gordon, J. T., and Jennings, A. S. (1983). Iodothyronine homeostasis in rat brain during hypo- and hyperthyroidism. Am. J. Physiol. 245, E185-E193.
28. Dratman, M. B., Futaesaku, Y., Crutchfield, F. L., Berman, N., Payne, B., Sar, M., et al. (1982). Iodine-125-labeled triiodothyronine in rat brain: evidence for localization in discrete neural systems. Science 215, 309-312. doi: 10.1126/science.7053582
29. Dugbartey, A. T. (1998). Neurocognitive aspects of hypothyroidism. Arch. Intern. Med. 158, 1413-1418. doi: 10.1001/archinte.158.13.1413
30. Emlen, W., Segal, D. S., and Mandell, A. J. (1972). Thyroid state: effects on pre- and postsynaptic central noradrenergic mechanisms. Science 175, 79-82. doi: 10.1126/science.175.4017.79
31. Guadaño-Ferraz, A., Escámez, M. J., Rausell, E., and Bernal, J. (1999). Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J. Neurosci. 19, 3430-3439.
32. Espinoza, S., Salahpour, A., Masri, B., Sotnikova, T. D., Messa, M., Barak, L. S., et al. (2011). Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol. Pharmacol. 80, 416-425. doi: 10.1124/mol.111.073304
33. Fliers, E., Klieverik, L. P., and Kalsbeek, A. (2010). Novel neural pathways for metabolic effects of thyroid hormone. Trends Endocrinol. Metab. 21, 230-236. doi: 10.1016/j.tem.2009.11.008
34. Frascarelli, S., Ghelardoni, S., Chiellini, G., Galli, E., Ronca, F., Scanlan, T. S., et al. (2011). Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. Cardiovasc. Drugs Ther. 25, 307-313. doi: 10.1007/s10557-011-6320-x
35. Frascarelli, S., Ghelardoni, S., Chiellini, G., Vargiu, R., Ronca-Testoni, S., Scanlan, T. S., et al. (2008). Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors. Eur. J. Pharmacol. 587, 231-236. doi: 10.1016/j.ejphar.2008.03.055
36. Galeotti, N., Malmberg-Aiello, P., Bartolini, A., Schunack, W., and Ghelardini, C. (2004). H1-receptor stimulation induces hyperalgesia through activation of the phospholipase C-PKC pathway. Neuropharmacology 47, 295-303. doi: 10.1016/j.neuropharm.2004.03.013
37. Galley, G., Stalder, H., Goergler, A., Hoener, M. C., and Norcross, R. D. (2012). Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012. Bioorg. Med. Chem. Lett. 22, 5244-5248. doi: 10.1016/j.bmcl.2012.06.060
38. Galli, E., Marchini, M., Saba, A., Berti, S., Tonacchera, M., Vitti, P., et al. (2012). Detection of 3-iodothyronamine in human patients: a preliminary study. J. Clin. Endocrinol. Metab. 97, E69-E74. doi: 10.1210/jc.2011-1115
39. Ghelardoni, S., Chiellini, G., Frascarelli, S., Saba, A., and Zucchi, R. (2014). Uptake and metabolic effects of 3-iodothyronamine (T1AM) in hepatocytes. J. Endocrinol. 13, 101-110. doi: 10.1530/JOE-13-0311
40. Ghelardoni, S., Suffredini, S., Frascarelli, S., Brogioni, S., Chiellini, G., Ronca-Testoni, S., et al. (2009). Modulation of cardiac calcium homeostasis by 3-iodothyronamine. J. Cell. Mol. Med. 13, 3082-3090. doi: 10.1111/j.1582-4934.2009.00728.x
41. Gilsbach, R., and Hein, L. (2012). Are the pharmacology and physiology of a2-adrenoceptors determined by a2-heteroreceptors and autoreceptors respectively? Br. J. Pharmacol. 165, 90-102. doi: 10.1111/j.1476-5381.2011.01533.x
42. Gompf, H. S., Greenberg, J. H., Aston-Jones, G., Ianculescu, A. G., Scanlan, T. S., and Dratman, M. B. (2010). 3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulator. Brain Res. 1351, 130-140. doi: 10.1016/j.brainres.2010.06.067
43. Gordon, J. T., Kaminski, D. M., Rozanov, C. B., and Dratman, M. B. (1999). Evidence that 3,3',5-triiodothyronine is concentrated in and delivered from the locus coeruleus to its noradrenergic targets via anterograde axonal transport. Neuroscience 93, 943-954. doi: 10.1016/S0306-4522(99)00146-3
44. Gordon, J. T., Rozanov, C. B., and Dratman, M. B. (1995). Endogenous Triiodothyronine (T3) localization in fiber tracts and neuronal cell groups of rat forebrain is reduced by acute administration of a specific Locus Coeruleus (LC) Lesioning Agent [abstract]. Thyroid 5, S87.
45. Grandy, D. K. (2007). Trace amine-associated receptor 1 - family archetype or iconoclast? Pharmacol. Ther. 116, 355-390 doi: 10.1016/j.pharmthera.2007.06.007
46. Greer, M. A., Murakami, M., and Tanaka, K. (1991). "Neuroendocrine relations in thyroid hormone metabolism," in Thyroid Hormone Metabolism: Regulation and Clinical Implications, Current Issues in Endocrinology and Metabolism, Vol 3, ed S. Y. Wu (Cambridge, MA: Blackwell Scientific Publications), 321-335.
47. Hackenmueller, S. A., Marchini, M., Saba, A., Zucchi, R., and Scanlan, T. S. (2012). Biosynthesis of 3-iodothyronamine (T1AM) is dependent on the sodium-iodide symporter and thyroperoxidase but does not involve extrathyroidal metabolism of T4. Endocrinology 153, 5659-5667. doi: 10.1210/en.2012-1254
48. Hackenmueller, S. A., and Scanlan, T. S. (2012). Identification and quantification of 3-iodothyronamine metabolites in mouse serum using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1256, 89-97. doi: 10.1016/j.chroma.2012.07.052
49. Hart, M. E., Suchland, K. L., Miyakawa, M., Bunzow, J. R., Grandy, D. K., and Scanlan, T. S. (2006). Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues. J. Med. Chem. 49, 1101-1112 doi: 10.1021/jm0505718
50. Haviland, J. A., Reiland, H., Butz, D. E., Tonelli, M., Porter, W. P., Zucchi, R., et al. (2013). NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T1AM treatment. Obesity 21, 2538-2544. doi: 10.1002/oby.20391
51. Hettinger, B. D., Schuff, K., Marks, D., and Scanlan, T. S. (2010). "3-iodothyronamine (T1AM) causes weight loss in mice via reduction in food consumption [abstract]," in 14th International Thyroid Congress, OC-141 (Paris).
52. Heuer, H., Maier, M. K., Iden, S., Mittag, J., Friesema, E. C., Visser, T. J., et al. (2005). The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146, 1701-1706. doi: 10.1210/en.2004-1179
53. Hoefig, C. S., Köhrle, J., Brabant, G., Dixit, K., Yap, B., Strasburger, C. J., et al. (2011). Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay. J. Clin. Endocrinol. Metab. 96, 1864-1872. doi: 10.1210/jc.2010-2680
54. Ianculescu, A. G., Giacomini, K. M., and Scanlan, T. S. (2009). Identification and characterization of 3-iodothyronamine (T1AM) intracellular transport. Endocrinology 150, 1991-1999. doi: 10.1210/en.2008-1339
55. Ianculescu, A. G., and Scanlan, T. S. (2010). 3-iodothyronamine (T1AM): a new chapter of thyroid hormone endocrinology? Mol. Biosyst. 6, 1338-1344. doi: 10.1039/b926583j
56. Ito, J. M., Valcana, T., and Timiras, P. S. (1977). Effect of hypo- and hyperthyroidism on regional monoamine metabolism in the adult rat brain. Neuroendocrinology 24, 55-64. doi: 10.1159/000122696
57. Ito, K., Uchida, Y., Ohtsuki, S., Aizawa, S., Kawakami, H., Katsukura, Y., et al. (2011). Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. J. Pharm. Sci. 100, 3939-3950. doi: 10.1002/jps.22487
58. Kakinuma, H., Itoh, M., and Takahashi, H. (2005). A novel mutation in the monocarboxylate transporter 8 gene in a boy with putamen lesions and low free T4 levels in cerebrospinal fluid. J. Pediatr. 147, 552-554. doi: 10.1016/j.jpeds.2005.05.012
59. Jackson, I. M. (1998). The thyroid axis and depression. Thyroid 8, 951-956. doi: 10.1089/thy.1998.8.951
60. James, T. D., Moffett, S. X., Scanlan, T. S., and Martin, J. V. (2013). Effects of acute microinjections of the thyroid hormone derivative 3-iodothyronamine to the preoptic region of adult male rats on sleep, thermoregulation and motor activity. Horm. Behav. 64, 81-88. doi: 10.1016/j.yhbeh.2013.05.004
61. Klieverik, L. P., Foppen, E., Ackermans, M. T., Serlie, M. J., Sauerwein, H. P., Scanlan, T. S., et al. (2009). Central effect of thyronamines on glucose metabolism in rats. J. Endocrinol. 201, 377-386. doi: 10.1677/JOE-09-0043
62. Kulikov, A., and Jeanningro, R. (2001). The Effects of hypothyroidism on 5-HT1A and 5-HT2A receptors and the serotonin transporter protein in the rat brain. Neurosci. Behav. Physiol. 31, 445-449. doi: 10.1023/A:1010401015064
63. Kulikov, A., Moreau, X., and Jeanningros, R. (1999). Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain. Neuroendocrinology 69, 453-459. doi: 10.1159/000054449
64. Lauder, J. M. (1983). Hormonal and humoral influences on brain development. Psychoneuroendocrinology 8, 121-155. doi: 10.1016/0306-4530(83)90053-7
65. Lee, J. S., Jang, B. S., Chung, C. M., Choi, I., Kim, J. G., and Park, S. H. (2013). In vivo molecular imaging of [125I]-labeled 3-iodothyronamine: a hibernation-inducing agent. Appl. Radiat. Isot. 73, 74-78. doi: 10.1016/j.apradiso.2012.11.017
66. Liggett, S. B. (2004). The two-timing thyroid. Nat. Med. 10, 582-583. doi: 10.1038/nm0604-582
67. Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaia, A., Ozmen, L., Bluethmann, H., et al. (2008). Trace amine-associated receptor 1 modulates dopaminergic activity. J. Pharmacol. Exp. Ther. 324, 948-956 doi: 10.1124/jpet.107.132647
68. Malmberg-Aiello, P., Lamberti, C., Ghelardini, C., Giotti, A., and Bartolini, A. (1994). Role of histamine in rodent antinociception. Br. J. Pharmacol. 111, 1269-1279. doi: 10.1111/j.1476-5381.1994.tb14883.x
69. Manni, M. E., De Siena, G., Saba, A., Marchini, M., Dicembrini, I., Bigagli, E., et al. (2012). 3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice. Br. J. Pharmacol. 166, 650-658. doi: 10.1111/j.1476-5381.2011.01823.x
70. Manni, M. E., De Siena, G., Saba, A., Marchini, M., Landucci, E., Gerace, E., et al. (2013). Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold. Br. J. Pharmacol. 168, 354-362. doi: 10.1111/j.1476-5381.2012.02137.x
71. Mariotti, V., Melissari, E., Iofrida, C., Righi, M., Di Russo, M., Donzelli, R., et al. (2014). Modulation of gene expression by 3-iodothyronamine: genetic evidence for a lipolytic pattern. PLoS ONE 32:P744. doi: 10.1530/endoabs.32.P744
72. Martí-Carbonell, M. A., Garau, A., Sala-Roca, J., and Balada, F. (2012). Effects of adult dysthyroidism on the morphology of hippocampal granular cells in rats. Acta. Neurobiol. Exp. (Wars) 72, 230-239. Available online at: http://www.ane.pl/home.php
73. Martin, J. V., Giannopoulos, P. F., Moffett, S. X., and James, T. D. (2013). Effects of acute microinjections of thyroid hormone to the preoptic region of euthyroid adult male rats on sleep and motor activity. Brain. Res. 1516, 45-54. doi: 10.1016/j.brainres.2013.01.032
74. Martin, J. V., Padron, J. M., Newman, M. A., Chapell, R., Leidenheimer, N. J., and Burke, L. A. (2004). Inhibition of the activity of the native gamma-aminobutyric acid A receptor by metabolites of thyroid hormones: correlations with molecular modeling studies. Brain. Res. 1004, 98-107. doi: 10.1016/j.brainres.2003.12.043
75. Mason, G. A., Walker, C. H., and Prange, A. J. Jr. (1987). Modulation of gamma-aminobutyric acid uptake of rat brain synaptosomes by thyroid hormones. Neuropsychopharmacology 1, 63-70. doi: 10.1016/0893-133X(87)90011-X
76. Moffett, S. X., Giannopoulos, P. F., James, T. D., and Martin, J. V. (2013). Effects of acute microinjections of thyroid hormone to the preoptic region of hypothyroid adult male rats on sleep, motor activity and body temperature. Brain Res. 1516, 55-65. doi: 10.1016/j.brainres.2013.04.017
77. Morreale de Escobar, G., Pastor, R., Obregon, M. J., and Escobar del Rey, F. (1985). Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 117, 1890-1900. doi: 10.1210/endo-117-5-1890
78. Mühlhaus, J., Pratzka, J., Piechowski, C. L., Krude, H., Grüters-Kieslich, A., Köhrle, J., et al. (2013). Diverse aspects of 3-T1AM induced signaling at human and mouse trace amine-associated receptor 5 (TAAR5) [abstract]. Eur. Thyroid J. 2, 176. doi: 10.1159/000353724
79. Mullur, R., Liu, Y. Y., and Brent, G. A. (2014). Thyroid hormone regulation of metabolism. Physiol. Rev. 94, 355-382. doi: 10.1152/physrev.00030.2013
80. Musilli, C., De Siena, G., Manni, M. E., Logli, A., Landucci, E., Zucchi, R., et al. (2014). Histamine mediates behavioral and metabolic effects of 3-iodothyroacetic acid (TA1), an endogenous end product of thyroid hormone metabolism. Br. J. Pharmacol. 171, 3476-3484. doi: 10.1111/bph.12697
81. Oguro, K., Ito, M., Tsuda, H., Mutoh, K., Shiraishi, H., Shirasaka, Y., et al. (1989). Interactions of thyroid hormones with L-(3H) glutamate binding sites, with special reference to N-methyl-D-aspartate receptors. Res. Commun. Chem. Pathol. Pharmacol. 65, 181-196.
82. Ookuma, K., Sakata, T., Fukagawa, K., Yoshimatsu, H., Kurokawa, M., Machidori, H., et al. (1993). Neuronal histamine in the hypo-thalamus suppresses food intake in rats. Brain Res. 628, 235-242. doi: 10.1016/0006-8993(93)90960-U
83. Panas, H. N., Lynch, L. J., Vallender, E. J., Xie, Z., Chen, G. L., Lynn, S. K., et al. (2010). Normal thermoregulatory response to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice. J. Neurosci. Res. 88, 1962-1969. doi: 10.1002/jnr.22367
84. Papay, R., Gaivin, R., Jha, A., McCune, D. F., McGrath, J. C., Rodrigo, M. C., et al. (2006). Localization of the mouse a1A- adrenergic receptor (AR) in the brain: a1AAR is expressed in neurons, GABAergic interneurons, and NG2 oligodendrocyte progenitors. J. Comp. Neurol. 497, 209-222. doi: 10.1002/cne.20992
85. Piehl, S., Heberer, T., Balizs, G., Scanlan, T. S., Smits, R., Koksch, B., et al. (2008). Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149, 3037-3045. doi: 10.1210/en.2007-1678
86. Piehl, S., Hoefig, C., Scanlan, T. S., and Köhrle, J. (2011). Thyronamines - past, present, and future. Endocr. Rev. 32, 64-80. doi: 10.1210/er.2009-0040
87. Pietsch, C. A., Scanlan, T. S., and Anderson, R. J. (2007). Thyronamines are substrates for human liver sulfotransferases. Endocrinology 148, 1921-1927. doi: 10.1210/en.2006-1172
88. Pinna, G., Brödel, O., Visser, T., Jeitner, A., Grau, H., Eravci, M., et al. (2002). Concentrations of seven iodothyronine metabolites in brain regions and the liver of the adult rat. Endocrinology 143, 1789-1800. doi: 10.1210/endo.143.5.8770
89. Puia, G., and Losi, G. (2011). Thyroid hormones modulate GABAA receptor-mediated currents in hippocampal neurons. Neuropharmacology 60, 1254-1261. doi: 10.1016/j.neuropharm.2010.12.013
90. Regard, J. B., Kataoka, H., Cano, D. A., Camerer, E., Yin, L., Zheng, Y. W., et al. (2007). Probing cell type-specific functions of Gi in vivo identifies GPCR regulators of insulin secretion. J. Clin. Invest. 117, 4034-4043. doi: 10.1172/JCI32994
91. Remaud, S., Gothié, J. D., Morvan-Dubois, G., and Demeneix, B. A. (2014). Thyroid hormone signaling and adult neurogenesis in mammals. Front Endocrinol. 5:62. doi: 10.3389/fendo.2014.00062
92. Revel, F. G., Moreau, J. L., Gainetdinov, R. R., Bradaia, A., Sotnikova, T. D., Mory, R., et al. (2011). TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc. Natl. Acad. Sci. U.S.A. 108, 8485-8490. doi: 10.1073/pnas.1103029108
93. Revel, F. G., Moreau, J. L., Pouzet, B., Mory, R., Bradaia, A., Buchy, D., et al. (2013). A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol. Psychiatry 18, 543-556. doi: 10.1038/mp.2012.57
94. Roy, G., Placzek, E., and Scanlan, T. S. (2012). Apo-B100-containing lipoproteins are major carriers of 3-iodothyronamine in circulation. J. Biol. Chem. 287, 1790-1800. doi: 10.1074/jbc.M111.275552
95. Rozanov, C. B., and Dratman, M. B. (1996). Evidence for selective localization of triiodothyronine in central noradrenergic systems. Neuroscience 74, 897-915. doi: 10.1016/0306-4522(96)00186-8
96. Saba, A., Chiellini, G., Frascarelli, S., Marchini, M., Ghelardoni, S., Raffaelli, A., et al. (2010). Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 151, 5063-5073. doi: 10.1210/en.2010-0491
97. Sara, S. J., and Devauges, V. (1988). Priming stimulation of locus coeruleus facilitates memory retrieval in the rat. Brain Res. 438, 299-303. doi: 10.1016/0006-8993(88)91351-0
98. Scanlan, T. S., Suchland, K. L., Hart, M. E., Chiellini, G., Huang, Y., Kruzich, P. J., et al. (2004). 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat. Med. 10, 638-642. doi: 10.1038/nm1051
99. Schöller, D. A., Brown, C., Nakamura, K., Nakagawa, A., Mazzeo, R. S., Brooks, G. A., et al. (1984). Influence of metabolic fuel on the 13C/12C ratio of breath CO2. Biomed Mass Spectrom. 11, 557-561. doi: 10.1002/bms.1200111103
100. Schwartz, H. L. (1983). "Effect of thyroid hormone on growth and development," in Molecular Basis of Thyroid Hormone Action, eds J. H. Oppenheimer and H. H. Samuels (New York, NY: Academic Press), 413-444. doi: 10.1016/B978-0-12-527560-6.50020-2
101. Smith, J. W., Evans, A. T., Costall, B., and Smythe, J. W. (2002). Thyroid hormones, brain function and cognition: a brief review. Neurosci. Biobehav. Rev. 26, 45-60. doi: 10.1016/S0149-7634(01)00037-9
102. Snead, A. N., Santos, M. S., Seal, R. P., Miyakawa, M., Edwards, R. H., and Scanlan, T. S. (2007). Thyronamines inhibit plasma membrane and vesicular monoamine transport. ACS Chem. Biol. 2, 390-398 doi: 10.1021/cb700057b
103. Strange, P. G. (2001). Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol. Rev. 53, 119-133.
104. Sugiyama, D., Kusuhara, H., Taniguchi, H., Ishikawa, S., Nozaki, Y., Aburatani, H., et al. (2003). Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J. Biol. Chem. 278, 43489-43495. doi: 10.1074/jbc.M306933200
105. Sullivan, R. M., Wilson, D. A., Lemon, C., and Gerhardt, G. A. (1994). Bilateral 6-OHDA lesions of the locus coeruleus impair associative olfactory learning in newborn rats. Brain Res. 643. 306-309 doi: 10.1016/0006-8993(94)90038-8
106. Tan, E. S., Miyakawa, M., Bunzow, J. R., Grandy, D. K., and Scanlan, T. S. (2007). Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1. J. Med. Chem. 50, 2787-2798 doi: 10.1021/jm0700417
107. Tan, E. S., Naylor, J. C., Groban, E. S., Bunzow, J. R., Jacobson, M. P., Grandy, D. K., et al. (2009). The molecular basis of species-specific ligand activation of trace amine-associated receptor 1 (TAAR1). ACS Chem. Biol. 4, 209-220. doi: 10.1021/cb800304d
108. Taskin, E., Artis, A. S., Bitiktas, S., Dolu, N., Liman, N., and Suer, C. (2011). Experimentally induced hyperthyroidism disrupts hippocampal long-term potentiation in adult rats. Neuroendocrinology 94, 218-227. doi: 10.1159/000328513
109. Venditti, P., Napolitano, G., Di Stefano, L., Chiellini, G., Zucchi, R., Scanlan, T. S., et al. (2011). Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity. Mol. Cell. Endocrinol. 341, 55-62. doi: 10.1016/j.mce.2011.05.013
110. Wood, W. J. L., Geraci, T., Nilsen, A., DeBarber, A., and Scanlan, T. S. (2009). Iodothyronamines are oxidatively deaminated to iodothyroacetic acids in vivo. Chembiochem 26, 361-365. doi: 10.1002/cbic.200800607
111. Zucchi, R., Chiellini, G., Scanlan, T. S., and Grandy, D. K. (2006). Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 149, 967-978 doi: 10.1038/sj.bjp.0706948